• Latest
Drugmakers yet to see gains from government’s minimum import price policy

Drugmakers yet to see gains from government’s minimum import price policy

June 23, 2026

Chronicles of Victory: October 23, 2020

October 23, 2026

Israel frees suspects in two settler attacks as West Bank pogroms intensify | Occupied West Bank News

October 23, 2026

Benjamin Netanyahu visits Leviathan platform, touts NIS 112 billion natural gas export

October 22, 2026

Sri Lanka chase 430 to beat England in historic ODI thriller

October 22, 2026

Tamil Nadu and Kerala White Papers: Why managing fiscal is a tightrope for State governments

October 22, 2026

His Majesty concludes state visit to the United Kingdom

October 23, 2026

Secretary shifted after transport dept complaints — Arabian Post

October 22, 2026

PHC bars arrest of inactive K-P deputy speaker, suspends eviction notice

October 23, 2026

Irish woman en route to one of Syria’s worst-hit cities to support child amputees

October 23, 2026

President Zardari embarks on three-day Germany visit to boost economic ties

October 22, 2026

PH Army holds medical mission in Lanao del Norte

October 22, 2026
ParityCube launches OpenTrust, a free fraud-number registry for Indian merchants

ParityCube launches OpenTrust, a free fraud-number registry for Indian merchants

October 22, 2026
Friday, October 23, 2026
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
Asia Today
No Result
View All Result
Subscribe
  • Login
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Sri Lanka
  • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • More News
    • Opinion
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Food
    • Health
    • Lifestyle
    • Science
    • Tech
    • Sports
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Sri Lanka
  • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • More News
    • Opinion
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Food
    • Health
    • Lifestyle
    • Science
    • Tech
    • Sports
No Result
View All Result
Morning News
No Result
View All Result
Home Health

Drugmakers yet to see gains from government’s minimum import price policy

by Asia Today Team
June 23, 2026
in Health
Reading Time: 2 mins read
21 1
A A
0
Drugmakers yet to see gains from government’s minimum import price policy
25
SHARES
309
VIEWS
Share on FacebookShare on Twitter

READ ALSO

Reykjavik Named Europe’s Best City for Sleep as Experts Warn of Widespread Sleep Deprivation

Carboplatin Injection: NATCO Pharma subsidiary launches Carboplatin in US market to address shortages


New Delhi: The federal government’s efforts to assist indigenous drug makers by means of the Minimal Import Worth (MIP) framework is but to see a transparent useful impression, a number of trade executives advised ET. Earlier this 12 months the federal government had restricted home pharmaceutical corporations from importing a couple of key uncooked supplies beneath a threshold pricing.

The MIP was set for some key pharmaceutical inputs like penicillin G and its salts, 6 APA and amoxicillin. In line with the notification from the Directorate Basic of Overseas Commerce (DGFT), the import worth for penicillin, a key uncooked materials for antibiotics, was set at ₹2,216 per kg, for amoxicillin the import worth was fastened at ₹2,733 per kg and ₹3,405 per kg for 6-APA.

Additionally Learn: Stress, poor sleep and processed meals are driving coronary heart assaults in younger Indians: Ramakanta Panda

“Demand is but to return and that raises considerations concerning the effectiveness of a coverage to bolster home pharmaceutical manufacturing,” one senior government advised ET. He added that the federal government’s clear intent to strengthen the Make in India agenda by means of the MIP mechanism has not discovered the anticipated traction from consumers, merchants, and completed dosage kind (FDF) producers who’ve been gradual or reluctant to pivot towards home suppliers at MIP linked costs.

“Because of this, a major put in capability is mendacity underutilised,” he added.

ET logo

Reside Occasions


Additionally Learn: India bans 16 fixed-dose drug mixtures over security considerations

Nonetheless, others say that it is a passing section. “Many consumers had stocked up closely on a couple of uncooked supplies in anticipation of MIP kicking in, and that could possibly be one of many causes for the lukewarm response,” he famous.He added he’s hopeful that the stockpiles at the moment are regularly being consumed and as soon as they run out, consumers will supply contemporary materials.

“We acquired the MIP in September 2025, pre-war, and until date we’ve low volumes regardless of having double the capability India wants. MIP on ATS-8 fully debunks the parable of demand and provide,” mentioned Namit Joshi, chairman, Pharmexcil.



Source link

Tags: drugmakersGainsGOVERNMENTSimportMinimumpolicyprice

Related Posts

Health

Reykjavik Named Europe’s Best City for Sleep as Experts Warn of Widespread Sleep Deprivation

October 22, 2026
Health

Carboplatin Injection: NATCO Pharma subsidiary launches Carboplatin in US market to address shortages

October 20, 2026
Health

Bus driver on attack in Haryana

October 19, 2026
Health

Biocon settles US patent dispute with Roche’s Genentech, eyes 2027 Perjeta biosimilar launch

October 16, 2026
Health

Tata Trusts Gets Until October 19 To Respond To Complaint

October 15, 2026
Health

Assessing products to counter side effects of GLP-1, says Bayer’s Triana

October 12, 2026
Asia Today

Copyright © 2022 Asia Today.

Navigate Site

  • Disclaimer
  • Privacy Policy
  • Cookie Privacy Policy
  • DMCA
  • Terms and Conditions
  • Contact us

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
  • World
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Sri Lanka
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • Opinion
  • Politics
  • Business
  • Entertainment
  • Fashion
  • Food
  • Health
  • Lifestyle
  • Science
  • Tech
  • Travel
  • Sports
  • About us
  • Advertise with us
  • Privacy Policy
  • Contact us
  • Support AsiaToday

Copyright © 2022 Asia Today.